Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms of isoniazid and rifampicin-induced liver injury and the effects of natural medicinal ingredients: A review. | Front Pharmacol | 2022 | 36299895 | PubTator, text mining | PubMed |
| Multifunctional role of natural products for the treatment of Parkinson's disease: At a glance. | Front Pharmacol | 2022 | 36299886 | PubTator, text mining | PubMed |
| Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline. | Pharmaceutics | 2022 | 36297437 | PubTator, text mining | PubMed |
| Isoniazid Linked to Sulfonate Esters via Hydrazone Functionality: Design, Synthesis, and Evaluation of Antitubercular Activity. | Pharmaceuticals (Basel) | 2022 | 36297413 | PubTator, text mining | PubMed |
| Whole Exome Sequencing and In Silico Analysis of Human Sertoli in Patients with Non-Obstructive Azoospermia. | Int J Mol Sci | 2022 | 36293429 | PubTator, text mining | PubMed |
| Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes. | Sci Rep | 2022 | 36289279 | PubTator, text mining | PubMed |
| Analyzing the metabolic fate of oral administration drugs: A review and state-of-the-art roadmap. | Front Pharmacol | 2022 | 36278150 | PubTator, text mining | PubMed |
| The genetics of occupational asthma development among workers exposed to diisocyanates: A systematic literature review with meta-analysis. | Front Genet | 2022 | 36276967 | PubTator, text mining | PubMed |
| In Vitro Models for Studying Chronic Drug-Induced Liver Injury. | Int J Mol Sci | 2022 | 36232728 | PubTator, text mining | PubMed |
| Protein Acetylation Going Viral: Implications in Antiviral Immunity and Viral Infection. | Int J Mol Sci | 2022 | 36232610 | PubTator, text mining | PubMed |
| GSTT1/GSTM1 Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian Patients. | Int J Mol Sci | 2022 | 36232322 | PubTator, text mining | PubMed |
| The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk? | Cancers (Basel) | 2022 | 36230700 | PubTator, text mining | PubMed |
| Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome. | Nat Med | 2022 | 36216932 | PubTator, text mining | PubMed |
| Dietary meat mutagens intake and cancer risk: A systematic review and meta-analysis. | Front Nutr | 2022 | 36211500 | PubTator, text mining | PubMed |
| Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma. | Oxid Med Cell Longev | 2022 | 36199423 | PubTator, text mining | PubMed |
| Bioinformatic identification of differentially expressed genes associated with hepatocellular carcinoma prognosis. | Medicine (Baltimore) | 2022 | 36197270 | PubTator, text mining | PubMed |
| Life factors acting on systemic lupus erythematosus. | Front Immunol | 2022 | 36189303 | PubTator, text mining | PubMed |
| Dissecting novel mechanisms of hepatitis B virus related hepatocellular carcinoma using meta-analysis of public data. | World J Gastrointest Oncol | 2022 | 36187396 | PubTator, text mining | PubMed |
| Isoniazid preventive therapy-related adverse events among Malawian adults on antiretroviral therapy: A cohort study. | Medicine (Baltimore) | 2022 | 36181120 | PubTator, text mining | PubMed |
| Identification and analysis of a CD8+ T cell-related prognostic signature for colorectal cancer based on bulk RNA sequencing and scRNA sequencing data: A STROBE-compliant retrospective study. | Medicine (Baltimore) | 2022 | 36181098 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=19